APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Premarital Genetic Testing

Compare research editions
View pricing & licenses

Selected research

Industry Research

Premarital Genetic Testing Industry Research Report 2026

Report ID 17421995054 June 2026146 pages

Choose your research edition.

Industry ResearchPremarital Genetic Testing Industry Research Report 2026146 pages · $2,950 USDIndustry Growth & TrendsGlobal Premarital Genetic Testing Industry Growth and Trends Forecast to 2032124 pages · $3,450 USDMarket StructureGlobal Premarital Genetic Testing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Premarital Genetic Testing Market Outlook and Growth Opportunities 2026213 pages · $4,250 USDMarket Analysis & ForecastGlobal Premarital Genetic Testing Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Premarital Genetic Testing market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

North America: the Premarital Genetic Testing market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Premarital Genetic Testing market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Premarital Genetic Testing market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Premarital Genetic Testing include NxGen MDx, LLC, OPKO Health, Gene by Gene, Sonic Genetics, MedGenome Labs, Centogene, LSI Medience, GC Genome and Illumina, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

Read the full market overview

This report quantifies the global Premarital Genetic Testing market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Premarital Genetic Testing.

Key Companies & Market Share Insights

This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Premarital Genetic Testing Market by Company

NxGen MDx, LLC

OPKO Health

Gene by Gene

Sonic Genetics

MedGenome Labs

Centogene

LSI Medience

GC Genome

Illumina

Fulgent Genetics

Natera

Clinical Labs

Eurofins Scientific

Myriad Genetics

Thermo Fisher Scientific

Genoma Group

SRL Inc.

Seegene

Huizhi Gene

My Baby Company

Invitae

Dian Diagnostics Group

Adicon

BGI

WuXi AppTec

Novogene

Berry Genomics

Kingmed Diagnostic

Zhongyuan Concord

AmoyDx

Premarital Genetic Testing Segment by Type

Single-Gene Genetic Disease Testing

Chromosomal Structural And Numerical Abnormality Testing

Polygenic Disease Risk Assessment

Mitochondrial And Maternal Genetic Testing

Pharmacogenomics And Functional Gene Testing

Premarital Genetic Testing Segment by Application

Male

Female

Premarital Genetic Testing Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Spain

Russia

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Saudi Arabia

Israel

United Arab Emirates

Turkey

Iran

Egypt

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Premarital Genetic Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Premarital Genetic Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Premarital Genetic Testing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 6: Detailed analysis of Premarital Genetic Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 13: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Premarital Genetic Testing Market Size by Type (2021-2026) & (US$ Million) Table 6. Global Premarital Genetic Testing Revenue Market Share by Type (2021-2026) Table 7. Global Premarital Genetic Testing Forecasted Market Size by Type (2027-2032) & (US$ Million) Table 8. Global Premarital Genetic Testing Revenue Market Share by Type (2027-2032) Table 9. Global Premarital Genetic Testing Market Size by Application (2021-2026) & (US$ Million) Table 10. Global Premarital Genetic Testing Revenue Market Share by Application (2021-2026) Table 11. Global Premarital Genetic Testing Forecasted Market Size by Application (2027-2032) & (US$ Million) Table 12. Global Premarital Genetic Testing Revenue Market Share by Application (2027-2032) Table 13. Global Premarital Genetic Testing Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Premarital Genetic Testing Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Premarital Genetic Testing Market Share by Region (2021-2026) Table 16. Global Premarital Genetic Testing Forecasted Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Premarital Genetic Testing Market Share by Region (2027-2032) Table 18. Premarital Genetic Testing Industry Trends Table 19. Premarital Genetic Testing Industry Drivers Table 20. Premarital Genetic Testing Industry Opportunities and Challenges Table 21. Premarital Genetic Testing Market Restraints Table 22. Global Top Premarital Genetic Testing Players by Revenue (US$ Million) & (2021-2026) Table 23. Global Premarital Genetic Testing Revenue Market Share by Players (2021-2026) Table 24. Global Premarital Genetic Testing Industry Players Ranking, 2024 VS 2025 VS 2026 Table 25. Global Key Players of Premarital Genetic Testing, Headquarters and Area Served Table 26. Global Premarital Genetic Testing Players, Product Type & Application Table 27. Global Players Market Concentration Ratio (CR5 and HHI) Table 28. Global Premarital Genetic Testing by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 29. Players Mergers & Acquisitions, Expansion Plans Table 30. North America Premarital Genetic Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 31. North America Premarital Genetic Testing Market Size by Country (2021-2026) & (US$ Million) Table 32. North America Premarital Genetic Testing Market Size by Country (2027-2032) & (US$ Million) Table 33. Europe Premarital Genetic Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Europe Premarital Genetic Testing Market Size by Country (2021-2026) & (US$ Million) Table 35. Europe Premarital Genetic Testing Market Size by Country (2027-2032) & (US$ Million) Table 36. Asia Pacific Premarital Genetic Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Asia Pacific Premarital Genetic Testing Market Size by Region (2021-2026) & (US$ Million) Table 38. Asia Pacific Premarital Genetic Testing Market Size by Country (2027-2032) & (US$ Million) Table 39. South America Premarital Genetic Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 40. South America Premarital Genetic Testing Market Size by Country (2021-2026) & (US$ Million) Table 41. South America Premarital Genetic Testing Market Size by Country (2027-2032) & (US$ Million) Table 42. Middle East & Africa Premarital Genetic Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 43. Middle East & Africa Premarital Genetic Testing Market Size by Country (2021-2026) & (US$ Million) Table 44. Middle East & Africa Premarital Genetic Testing Market Size by Country (2027-2032) & (US$ Million) Table 45. NxGen MDx, LLC Company Information Table 46. NxGen MDx, LLC Business Overview Table 47. NxGen MDx, LLC Revenue in Premarital Genetic Testing Business (2021-2026) & (US$ Million) Table 48. NxGen MDx, LLC Premarital Genetic Testing Product Portfolio Table 49. NxGen MDx, LLC Recent Developments Table 50. OPKO Health Company Information Table 51. OPKO Health Business Overview Table 52. OPKO Health Revenue in Premarital Genetic Testing Business (2021-2026) & (US$ Million) Table 53. OPKO Health Premarital Genetic Testing Product Portfolio Table 54. OPKO Health Recent Developments Table 55. Gene by Gene Company Information Table 56. Gene by Gene Business Overview Table 57. Gene by Gene Revenue in Premarital Genetic Testing Business (2021-2026) & (US$ Million) Table 58. Gene by Gene Premarital Genetic Testing Product Portfolio Table 59. Gene by Gene Recent Developments Table 60. Sonic Genetics Company Information Table 61. Sonic Genetics Business Overview Table 62. Sonic Genetics Revenue in Premarital Genetic Testing Business (2021-2026) & (US$ Million) Table 63. Sonic Genetics Premarital Genetic Testing Product Portfolio Table 64. Sonic Genetics Recent Developments Table 65. MedGenome Labs Company Information Table 66. MedGenome Labs Business Overview Table 67. MedGenome Labs Revenue in Premarital Genetic Testing Business (2021-2026) & (US$ Million) Table 68. MedGenome Labs Premarital Genetic Testing Product Portfolio Table 69. MedGenome Labs Recent Developments Table 70. Centogene Company Information Table 71. Centogene Business Overview Table 72. Centogene Revenue in Premarital Genetic Testing Business (2021-2026) & (US$ Million) Table 73. Centogene Premarital Genetic Testing Product Portfolio Table 74. Centogene Recent Developments Table 75. LSI Medience Company Information Table 76. LSI Medience Business Overview Table 77. LSI Medience Revenue in Premarital Genetic Testing Business (2021-2026) & (US$ Million) Table 78. LSI Medience Premarital Genetic Testing Product Portfolio Table 79. LSI Medience Recent Developments Table 80. GC Genome Company Information Table 81. GC Genome Business Overview Table 82. GC Genome Revenue in Premarital Genetic Testing Business (2021-2026) & (US$ Million) Table 83. GC Genome Premarital Genetic Testing Product Portfolio Table 84. GC Genome Recent Developments Table 85. Illumina Company Information Table 86. Illumina Business Overview Table 87. Illumina Revenue in Premarital Genetic Testing Business (2021-2026) & (US$ Million) Table 88. Illumina Premarital Genetic Testing Product Portfolio Table 89. Illumina Recent Developments Table 90. Fulgent Genetics Company Information Table 91. Fulgent Genetics Business Overview Table 92. Fulgent Genetics Revenue in Premarital Genetic Testing Business (2021-2026) & (US$ Million) Table 93. Fulgent Genetics Premarital Genetic Testing Product Portfolio Table 94. Fulgent Genetics Recent Developments Table 95. Natera Company Information Table 96. Natera Business Overview Table 97. Natera Revenue in Premarital Genetic Testing Business (2021-2026) & (US$ Million) Table 98. Natera Premarital Genetic Testing Product Portfolio Table 99. Natera Recent Developments Table 100. Clinical Labs Company Information Table 101. Clinical Labs Business Overview Table 102. Clinical Labs Revenue in Premarital Genetic Testing Business (2021-2026) & (US$ Million) Table 103. Clinical Labs Premarital Genetic Testing Product Portfolio Table 104. Clinical Labs Recent Developments Table 105. Eurofins Scientific Company Information Table 106. Eurofins Scientific Business Overview Table 107. Eurofins Scientific Revenue in Premarital Genetic Testing Business (2021-2026) & (US$ Million) Table 108. Eurofins Scientific Premarital Genetic Testing Product Portfolio Table 109. Eurofins Scientific Recent Developments Table 110. Myriad Genetics Company Information Table 111. Myriad Genetics Business Overview Table 112. Myriad Genetics Revenue in Premarital Genetic Testing Business (2021-2026) & (US$ Million) Table 113. Myriad Genetics Premarital Genetic Testing Product Portfolio Table 114. Myriad Genetics Recent Developments Table 115. Thermo Fisher Scientific Company Information Table 116. Thermo Fisher Scientific Business Overview Table 117. Thermo Fisher Scientific Revenue in Premarital Genetic Testing Business (2021-2026) & (US$ Million) Table 118. Thermo Fisher Scientific Premarital Genetic Testing Product Portfolio Table 119. Thermo Fisher Scientific Recent Developments Table 120. Genoma Group Company Information Table 121. Genoma Group Business Overview Table 122. Genoma Group Revenue in Premarital Genetic Testing Business (2021-2026) & (US$ Million) Table 123. Genoma Group Premarital Genetic Testing Product Portfolio Table 124. Genoma Group Recent Developments Table 125. SRL Inc. Company Information Table 126. SRL Inc. Business Overview Table 127. SRL Inc. Revenue in Premarital Genetic Testing Business (2021-2026) & (US$ Million) Table 128. SRL Inc. Premarital Genetic Testing Product Portfolio Table 129. SRL Inc. Recent Developments Table 130. Seegene Company Information Table 131. Seegene Business Overview Table 132. Seegene Revenue in Premarital Genetic Testing Business (2021-2026) & (US$ Million) Table 133. Seegene Premarital Genetic Testing Product Portfolio Table 134. Seegene Recent Developments Table 135. Huizhi Gene Company Information Table 136. Huizhi Gene Business Overview Table 137. Huizhi Gene Revenue in Premarital Genetic Testing Business (2021-2026) & (US$ Million) Table 138. Huizhi Gene Premarital Genetic Testing Product Portfolio Table 139. Huizhi Gene Recent Developments Table 140. My Baby Company Company Information Table 141. My Baby Company Business Overview Table 142. My Baby Company Revenue in Premarital Genetic Testing Business (2021-2026) & (US$ Million) Table 143. My Baby Company Premarital Genetic Testing Product Portfolio Table 144. My Baby Company Recent Developments Table 145. Invitae Company Information Table 146. Invitae Business Overview Table 147. Invitae Revenue in Premarital Genetic Testing Business (2021-2026) & (US$ Million) Table 148. Invitae Premarital Genetic Testing Product Portfolio Table 149. Invitae Recent Developments Table 150. Dian Diagnostics Group Company Information Table 151. Dian Diagnostics Group Business Overview Table 152. Dian Diagnostics Group Revenue in Premarital Genetic Testing Business (2021-2026) & (US$ Million) Table 153. Dian Diagnostics Group Premarital Genetic Testing Product Portfolio Table 154. Dian Diagnostics Group Recent Developments Table 155. Adicon Company Information Table 156. Adicon Business Overview Table 157. Adicon Revenue in Premarital Genetic Testing Business (2021-2026) & (US$ Million) Table 158. Adicon Premarital Genetic Testing Product Portfolio Table 159. Adicon Recent Developments Table 160. BGI Company Information Table 161. BGI Business Overview Table 162. BGI Revenue in Premarital Genetic Testing Business (2021-2026) & (US$ Million) Table 163. BGI Premarital Genetic Testing Product Portfolio Table 164. BGI Recent Developments Table 165. WuXi AppTec Company Information Table 166. WuXi AppTec Business Overview Table 167. WuXi AppTec Revenue in Premarital Genetic Testing Business (2021-2026) & (US$ Million) Table 168. WuXi AppTec Premarital Genetic Testing Product Portfolio Table 169. WuXi AppTec Recent Developments Table 170. Novogene Company Information Table 171. Novogene Business Overview Table 172. Novogene Revenue in Premarital Genetic Testing Business (2021-2026) & (US$ Million) Table 173. Novogene Premarital Genetic Testing Product Portfolio Table 174. Novogene Recent Developments Table 175. Berry Genomics Company Information Table 176. Berry Genomics Business Overview Table 177. Berry Genomics Revenue in Premarital Genetic Testing Business (2021-2026) & (US$ Million) Table 178. Berry Genomics Premarital Genetic Testing Product Portfolio Table 179. Berry Genomics Recent Developments Table 180. Kingmed Diagnostic Company Information Table 181. Kingmed Diagnostic Business Overview Table 182. Kingmed Diagnostic Revenue in Premarital Genetic Testing Business (2021-2026) & (US$ Million) Table 183. Kingmed Diagnostic Premarital Genetic Testing Product Portfolio Table 184. Kingmed Diagnostic Recent Developments Table 185. Zhongyuan Concord Company Information Table 186. Zhongyuan Concord Business Overview Table 187. Zhongyuan Concord Revenue in Premarital Genetic Testing Business (2021-2026) & (US$ Million) Table 188. Zhongyuan Concord Premarital Genetic Testing Product Portfolio Table 189. Zhongyuan Concord Recent Developments Table 190. AmoyDx Company Information Table 191. AmoyDx Business Overview Table 192. AmoyDx Revenue in Premarital Genetic Testing Business (2021-2026) & (US$ Million) Table 193. AmoyDx Premarital Genetic Testing Product Portfolio Table 194. AmoyDx Recent Developments Table 195. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Premarital Genetic Testing Product Image Figure 5. Global Premarital Genetic Testing Market Size Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 6. Global Premarital Genetic Testing Market Share by Type: 2025 VS 2032 Figure 7. Single-Gene Genetic Disease Testing Product Figure 8. Chromosomal Structural And Numerical Abnormality Testing Product Figure 9. Polygenic Disease Risk Assessment Product Figure 10. Mitochondrial And Maternal Genetic Testing Product Figure 11. Pharmacogenomics And Functional Gene Testing Product Figure 12. Global Premarital Genetic Testing Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 13. Global Premarital Genetic Testing Market Share by Application: 2025 VS 2032 Figure 14. Male Product Figure 15. Female Product Figure 16. Global Premarital Genetic Testing Market Size (US$ Million), Year-over-Year: 2021-2032 Figure 17. Global Premarital Genetic Testing Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 18. Global Premarital Genetic Testing Market Share by Region: 2025 VS 2032 Figure 19. Global Premarital Genetic Testing Market Share by Players in 2025 Figure 20. Global Premarital Genetic Testing Manufacturers Established Date Figure 21. Global Top 5 and 10 Premarital Genetic Testing Players Market Share by Revenue in 2025 Figure 22. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. North America Premarital Genetic Testing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 24. North America Premarital Genetic Testing Market Share by Country (2021-2032) Figure 25. United States Premarital Genetic Testing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 26. Canada Premarital Genetic Testing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Mexico Premarital Genetic Testing Market Share by Country (2021-2032) Figure 28. Europe Premarital Genetic Testing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Europe Premarital Genetic Testing Market Share by Country (2021-2032) Figure 30. Germany Premarital Genetic Testing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. France Premarital Genetic Testing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 32. U.K. Premarital Genetic Testing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Italy Premarital Genetic Testing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 34. Spain Premarital Genetic Testing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Russia Premarital Genetic Testing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 36. Netherlands Premarital Genetic Testing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 37. Nordic Countries Premarital Genetic Testing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 38. Asia-Pacific Premarital Genetic Testing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 39. Asia-Pacific Premarital Genetic Testing Market Share by Country (2021-2032) Figure 40. China Premarital Genetic Testing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 41. Japan Premarital Genetic Testing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 42. South Korea Premarital Genetic Testing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 43. India Premarital Genetic Testing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 44. India Premarital Genetic Testing Market Share by Country (2021-2032) Figure 45. Australia Premarital Genetic Testing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 46. China Taiwan Premarital Genetic Testing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 47. Southeast Asia Premarital Genetic Testing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 48. South America Premarital Genetic Testing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 49. South America Premarital Genetic Testing Market Share by Country (2021-2032) Figure 50. Brazil Premarital Genetic Testing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 51. Argentina Premarital Genetic Testing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 52. Chile Premarital Genetic Testing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 53. Colombia Premarital Genetic Testing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 54. Peru Premarital Genetic Testing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 55. NxGen MDx, LLC Revenue Growth Rate in Premarital Genetic Testing Business (2021-2026) Figure 56. OPKO Health Revenue Growth Rate in Premarital Genetic Testing Business (2021-2026) Figure 57. Gene by Gene Revenue Growth Rate in Premarital Genetic Testing Business (2021-2026) Figure 58. Sonic Genetics Revenue Growth Rate in Premarital Genetic Testing Business (2021-2026) Figure 59. MedGenome Labs Revenue Growth Rate in Premarital Genetic Testing Business (2021-2026) Figure 60. Centogene Revenue Growth Rate in Premarital Genetic Testing Business (2021-2026) Figure 61. LSI Medience Revenue Growth Rate in Premarital Genetic Testing Business (2021-2026) Figure 62. GC Genome Revenue Growth Rate in Premarital Genetic Testing Business (2021-2026) Figure 63. Illumina Revenue Growth Rate in Premarital Genetic Testing Business (2021-2026) Figure 64. Fulgent Genetics Revenue Growth Rate in Premarital Genetic Testing Business (2021-2026) Figure 65. Natera Revenue Growth Rate in Premarital Genetic Testing Business (2021-2026) Figure 66. Clinical Labs Revenue Growth Rate in Premarital Genetic Testing Business (2021-2026) Figure 67. Eurofins Scientific Revenue Growth Rate in Premarital Genetic Testing Business (2021-2026) Figure 68. Myriad Genetics Revenue Growth Rate in Premarital Genetic Testing Business (2021-2026) Figure 69. Thermo Fisher Scientific Revenue Growth Rate in Premarital Genetic Testing Business (2021-2026) Figure 70. Genoma Group Revenue Growth Rate in Premarital Genetic Testing Business (2021-2026) Figure 71. SRL Inc. Revenue Growth Rate in Premarital Genetic Testing Business (2021-2026) Figure 72. Seegene Revenue Growth Rate in Premarital Genetic Testing Business (2021-2026) Figure 73. Huizhi Gene Revenue Growth Rate in Premarital Genetic Testing Business (2021-2026) Figure 74. My Baby Company Revenue Growth Rate in Premarital Genetic Testing Business (2021-2026) Figure 75. Invitae Revenue Growth Rate in Premarital Genetic Testing Business (2021-2026) Figure 76. Dian Diagnostics Group Revenue Growth Rate in Premarital Genetic Testing Business (2021-2026) Figure 77. Adicon Revenue Growth Rate in Premarital Genetic Testing Business (2021-2026) Figure 78. BGI Revenue Growth Rate in Premarital Genetic Testing Business (2021-2026) Figure 79. WuXi AppTec Revenue Growth Rate in Premarital Genetic Testing Business (2021-2026) Figure 80. Novogene Revenue Growth Rate in Premarital Genetic Testing Business (2021-2026) Figure 81. Berry Genomics Revenue Growth Rate in Premarital Genetic Testing Business (2021-2026) Figure 82. Kingmed Diagnostic Revenue Growth Rate in Premarital Genetic Testing Business (2021-2026) Figure 83. Zhongyuan Concord Revenue Growth Rate in Premarital Genetic Testing Business (2021-2026) Figure 84. AmoyDx Revenue Growth Rate in Premarital Genetic Testing Business (2021-2026)

Scope & coverage.

Types
  • Single-Gene Genetic Disease Testing
  • Chromosomal Structural And Numerical Abnormality Testing
  • Polygenic Disease Risk Assessment
  • Mitochondrial And Maternal Genetic Testing
  • Pharmacogenomics And Functional Gene Testing
Applications
  • Male
  • Female
Companies covered
  • NxGen MDx, LLC
  • OPKO Health
  • Gene by Gene
  • Sonic Genetics
  • MedGenome Labs
  • Centogene
  • LSI Medience
  • GC Genome
  • Illumina
  • Fulgent Genetics
  • Natera
  • Clinical Labs
  • Eurofins Scientific
  • Myriad Genetics
  • Thermo Fisher Scientific
  • Genoma Group
  • SRL Inc.
  • Seegene
  • Huizhi Gene
  • My Baby Company
  • Invitae
  • Dian Diagnostics Group
  • Adicon
  • BGI
  • WuXi AppTec
  • Novogene
  • Berry Genomics
  • Kingmed Diagnostic
  • Zhongyuan Concord
  • AmoyDx

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Premarital Genetic Testing by Type
  3. 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
  4. 2.2.2 Single-Gene Genetic Disease Testing
  5. 2.2.3 Chromosomal Structural And Numerical Abnormality Testing
  6. 2.2.4 Polygenic Disease Risk Assessment
  7. 2.2.5 Mitochondrial And Maternal Genetic Testing
  8. 2.2.6 Pharmacogenomics And Functional Gene Testing
  9. 2.3 Premarital Genetic Testing by Application
  10. 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  11. 2.3.2 Male
  12. 2.3.3 Female
  13. 2.4 Assumptions and Limitations
3 Premarital Genetic Testing Breakdown Data by Type
  1. 3.1 Global Premarital Genetic Testing Historic Market Size by Type (2021-2026)
  2. 3.2 Global Premarital Genetic Testing Forecasted Market Size by Type (2027-2032)
4 Premarital Genetic Testing Breakdown Data by Application
  1. 4.1 Global Premarital Genetic Testing Historic Market Size by Application (2021-2026)
  2. 4.2 Global Premarital Genetic Testing Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
  1. 5.1 Global Premarital Genetic Testing Market Perspective (2021-2032)
  2. 5.2 Global Premarital Genetic Testing Growth Trends by Region
  3. 5.2.1 Global Premarital Genetic Testing Market Size by Region: 2021 VS 2025 VS 2032
  4. 5.2.2 Premarital Genetic Testing Historic Market Size by Region (2021-2026)
  5. 5.2.3 Premarital Genetic Testing Forecasted Market Size by Region (2027-2032)
  6. 5.3 Premarital Genetic Testing Market Dynamics
  7. 5.3.1 Premarital Genetic Testing Industry Trends
  8. 5.3.2 Premarital Genetic Testing Market Drivers
  9. 5.3.3 Premarital Genetic Testing Market Challenges
  10. 5.3.4 Premarital Genetic Testing Market Restraints
6 Market Competitive Landscape by Players
  1. 6.1 Global Top Premarital Genetic Testing Players by Revenue
  2. 6.1.1 Global Top Premarital Genetic Testing Players by Revenue (2021-2026)
  3. 6.1.2 Global Premarital Genetic Testing Revenue Market Share by Players (2021-2026)
  4. 6.2 Global Premarital Genetic Testing Industry Players Ranking, 2023 VS 2024 VS 2025
  5. 6.3 Global Key Players of Premarital Genetic Testing Head Office and Area Served
  6. 6.4 Global Premarital Genetic Testing Players, Product Type & Application
  7. 6.5 Global Premarital Genetic Testing Manufacturers Established Date
  8. 6.6 Global Premarital Genetic Testing Market CR5 and HHI
  9. 6.7 Global Players Mergers & Acquisition
7 North America
  1. 7.1 North America Premarital Genetic Testing Market Size (2021-2032)
  2. 7.2 North America Premarital Genetic Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 7.3 North America Premarital Genetic Testing Market Size by Country (2021-2026)
  4. 7.4 North America Premarital Genetic Testing Market Size by Country (2027-2032)
  5. 7.5 United States
  6. 7.5 United States
  7. 7.6 Canada
  8. 7.7 Mexico
8 Europe
  1. 8.1 Europe Premarital Genetic Testing Market Size (2021-2032)
  2. 8.2 Europe Premarital Genetic Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 8.3 Europe Premarital Genetic Testing Market Size by Country (2021-2026)
  4. 8.4 Europe Premarital Genetic Testing Market Size by Country (2027-2032)
  5. 8.5 Germany
  6. 8.6 France
  7. 8.7 U.K.
  8. 8.8 Italy
  9. 8.9 Spain
  10. 8.10 Russia
  11. 8.11 Netherlands
  12. 8.12 Nordic Countries
9 Asia-Pacific
  1. 9.1 Asia-Pacific Premarital Genetic Testing Market Size (2021-2032)
  2. 9.2 Asia-Pacific Premarital Genetic Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 9.3 Asia-Pacific Premarital Genetic Testing Market Size by Country (2021-2026)
  4. 9.4 Asia-Pacific Premarital Genetic Testing Market Size by Country (2027-2032)
  5. 9.5 China
  6. 9.6 Japan
  7. 9.7 South Korea
  8. 9.8 India
  9. 9.9 Australia
  10. 9.10 China Taiwan
  11. 9.11 Southeast Asia
10 South America
  1. 10.1 South America Premarital Genetic Testing Market Size (2021-2032)
  2. 10.2 South America Premarital Genetic Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 10.3 South America Premarital Genetic Testing Market Size by Country (2021-2026)
  4. 10.4 South America Premarital Genetic Testing Market Size by Country (2027-2032)
  5. 10.5 Brazil
  6. 10.6 Argentina
  7. 10.7 Chile
  8. 10.8 Colombia
  9. 10.9 Peru
11 Middle East & Africa
  1. 11.1 Middle East & Africa Premarital Genetic Testing Market Size (2021-2032)
  2. 11.2 Middle East & Africa Premarital Genetic Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 11.3 Middle East & Africa Premarital Genetic Testing Market Size by Country (2021-2026)
  4. 11.4 Middle East & Africa Premarital Genetic Testing Market Size by Country (2027-2032)
  5. 11.5 Saudi Arabia
  6. 11.6 Israel
  7. 11.7 United Arab Emirates
  8. 11.8 Turkey
  9. 11.9 Iran
  10. 11.10 Egypt
12 Players Profiled
  1. 12.1 NxGen MDx, LLC
  2. 12.1.1 NxGen MDx, LLC Company Information
  3. 12.1.2 NxGen MDx, LLC Business Overview
  4. 12.1.3 NxGen MDx, LLC Revenue in Premarital Genetic Testing Business (2021-2026)
  5. 12.1.4 NxGen MDx, LLC Premarital Genetic Testing Product Portfolio
  6. 12.1.5 NxGen MDx, LLC Recent Developments
  7. 12.2 OPKO Health
  8. 12.2.1 OPKO Health Company Information
  9. 12.2.2 OPKO Health Business Overview
  10. 12.2.3 OPKO Health Revenue in Premarital Genetic Testing Business (2021-2026)
  11. 12.2.4 OPKO Health Premarital Genetic Testing Product Portfolio
  12. 12.2.5 OPKO Health Recent Developments
  13. 12.3 Gene by Gene
  14. 12.3.1 Gene by Gene Company Information
  15. 12.3.2 Gene by Gene Business Overview
  16. 12.3.3 Gene by Gene Revenue in Premarital Genetic Testing Business (2021-2026)
  17. 12.3.4 Gene by Gene Premarital Genetic Testing Product Portfolio
  18. 12.3.5 Gene by Gene Recent Developments
  19. 12.4 Sonic Genetics
  20. 12.4.1 Sonic Genetics Company Information
  21. 12.4.2 Sonic Genetics Business Overview
  22. 12.4.3 Sonic Genetics Revenue in Premarital Genetic Testing Business (2021-2026)
  23. 12.4.4 Sonic Genetics Premarital Genetic Testing Product Portfolio
  24. 12.4.5 Sonic Genetics Recent Developments
  25. 12.5 MedGenome Labs
  26. 12.5.1 MedGenome Labs Company Information
  27. 12.5.2 MedGenome Labs Business Overview
  28. 12.5.3 MedGenome Labs Revenue in Premarital Genetic Testing Business (2021-2026)
  29. 12.5.4 MedGenome Labs Premarital Genetic Testing Product Portfolio
  30. 12.5.5 MedGenome Labs Recent Developments
  31. 12.6 Centogene
  32. 12.6.1 Centogene Company Information
  33. 12.6.2 Centogene Business Overview
  34. 12.6.3 Centogene Revenue in Premarital Genetic Testing Business (2021-2026)
  35. 12.6.4 Centogene Premarital Genetic Testing Product Portfolio
  36. 12.6.5 Centogene Recent Developments
  37. 12.7 LSI Medience
  38. 12.7.1 LSI Medience Company Information
  39. 12.7.2 LSI Medience Business Overview
  40. 12.7.3 LSI Medience Revenue in Premarital Genetic Testing Business (2021-2026)
  41. 12.7.4 LSI Medience Premarital Genetic Testing Product Portfolio
  42. 12.7.5 LSI Medience Recent Developments
  43. 12.8 GC Genome
  44. 12.8.1 GC Genome Company Information
  45. 12.8.2 GC Genome Business Overview
  46. 12.8.3 GC Genome Revenue in Premarital Genetic Testing Business (2021-2026)
  47. 12.8.4 GC Genome Premarital Genetic Testing Product Portfolio
  48. 12.8.5 GC Genome Recent Developments
  49. 12.9 Illumina
  50. 12.9.1 Illumina Company Information
  51. 12.9.2 Illumina Business Overview
  52. 12.9.3 Illumina Revenue in Premarital Genetic Testing Business (2021-2026)
  53. 12.9.4 Illumina Premarital Genetic Testing Product Portfolio
  54. 12.9.5 Illumina Recent Developments
  55. 12.10 Fulgent Genetics
  56. 12.10.1 Fulgent Genetics Company Information
  57. 12.10.2 Fulgent Genetics Business Overview
  58. 12.10.3 Fulgent Genetics Revenue in Premarital Genetic Testing Business (2021-2026)
  59. 12.10.4 Fulgent Genetics Premarital Genetic Testing Product Portfolio
  60. 12.10.5 Fulgent Genetics Recent Developments
  61. 12.11 Natera
  62. 12.11.1 Natera Company Information
  63. 12.11.2 Natera Business Overview
  64. 12.11.3 Natera Revenue in Premarital Genetic Testing Business (2021-2026)
  65. 12.11.4 Natera Premarital Genetic Testing Product Portfolio
  66. 12.11.5 Natera Recent Developments
  67. 12.12 Clinical Labs
  68. 12.12.1 Clinical Labs Company Information
  69. 12.12.2 Clinical Labs Business Overview
  70. 12.12.3 Clinical Labs Revenue in Premarital Genetic Testing Business (2021-2026)
  71. 12.12.4 Clinical Labs Premarital Genetic Testing Product Portfolio
  72. 12.12.5 Clinical Labs Recent Developments
  73. 12.13 Eurofins Scientific
  74. 12.13.1 Eurofins Scientific Company Information
  75. 12.13.2 Eurofins Scientific Business Overview
  76. 12.13.3 Eurofins Scientific Revenue in Premarital Genetic Testing Business (2021-2026)
  77. 12.13.4 Eurofins Scientific Premarital Genetic Testing Product Portfolio
  78. 12.13.5 Eurofins Scientific Recent Developments
  79. 12.14 Myriad Genetics
  80. 12.14.1 Myriad Genetics Company Information
  81. 12.14.2 Myriad Genetics Business Overview
  82. 12.14.3 Myriad Genetics Revenue in Premarital Genetic Testing Business (2021-2026)
  83. 12.14.4 Myriad Genetics Premarital Genetic Testing Product Portfolio
  84. 12.14.5 Myriad Genetics Recent Developments
  85. 12.15 Thermo Fisher Scientific
  86. 12.15.1 Thermo Fisher Scientific Company Information
  87. 12.15.2 Thermo Fisher Scientific Business Overview
  88. 12.15.3 Thermo Fisher Scientific Revenue in Premarital Genetic Testing Business (2021-2026)
  89. 12.15.4 Thermo Fisher Scientific Premarital Genetic Testing Product Portfolio
  90. 12.15.5 Thermo Fisher Scientific Recent Developments
  91. 12.16 Genoma Group
  92. 12.16.1 Genoma Group Company Information
  93. 12.16.2 Genoma Group Business Overview
  94. 12.16.3 Genoma Group Revenue in Premarital Genetic Testing Business (2021-2026)
  95. 12.16.4 Genoma Group Premarital Genetic Testing Product Portfolio
  96. 12.16.5 Genoma Group Recent Developments
  97. 12.17 SRL Inc.
  98. 12.17.1 SRL Inc. Company Information
  99. 12.17.2 SRL Inc. Business Overview
  100. 12.17.3 SRL Inc. Revenue in Premarital Genetic Testing Business (2021-2026)
  101. 12.17.4 SRL Inc. Premarital Genetic Testing Product Portfolio
  102. 12.17.5 SRL Inc. Recent Developments
  103. 12.18 Seegene
  104. 12.18.1 Seegene Company Information
  105. 12.18.2 Seegene Business Overview
  106. 12.18.3 Seegene Revenue in Premarital Genetic Testing Business (2021-2026)
  107. 12.18.4 Seegene Premarital Genetic Testing Product Portfolio
  108. 12.18.5 Seegene Recent Developments
  109. 12.19 Huizhi Gene
  110. 12.19.1 Huizhi Gene Company Information
  111. 12.19.2 Huizhi Gene Business Overview
  112. 12.19.3 Huizhi Gene Revenue in Premarital Genetic Testing Business (2021-2026)
  113. 12.19.4 Huizhi Gene Premarital Genetic Testing Product Portfolio
  114. 12.19.5 Huizhi Gene Recent Developments
  115. 12.20 My Baby Company
  116. 12.20.1 My Baby Company Company Information
  117. 12.20.2 My Baby Company Business Overview
  118. 12.20.3 My Baby Company Revenue in Premarital Genetic Testing Business (2021-2026)
  119. 12.20.4 My Baby Company Premarital Genetic Testing Product Portfolio
  120. 12.20.5 My Baby Company Recent Developments
  121. 12.21 Invitae
  122. 12.21.1 Invitae Company Information
  123. 12.21.2 Invitae Business Overview
  124. 12.21.3 Invitae Revenue in Premarital Genetic Testing Business (2021-2026)
  125. 12.21.4 Invitae Premarital Genetic Testing Product Portfolio
  126. 12.21.5 Invitae Recent Developments
  127. 12.22 Dian Diagnostics Group
  128. 12.22.1 Dian Diagnostics Group Company Information
  129. 12.22.2 Dian Diagnostics Group Business Overview
  130. 12.22.3 Dian Diagnostics Group Revenue in Premarital Genetic Testing Business (2021-2026)
  131. 12.22.4 Dian Diagnostics Group Premarital Genetic Testing Product Portfolio
  132. 12.22.5 Dian Diagnostics Group Recent Developments
  133. 12.23 Adicon
  134. 12.23.1 Adicon Company Information
  135. 12.23.2 Adicon Business Overview
  136. 12.23.3 Adicon Revenue in Premarital Genetic Testing Business (2021-2026)
  137. 12.23.4 Adicon Premarital Genetic Testing Product Portfolio
  138. 12.23.5 Adicon Recent Developments
  139. 12.24 BGI
  140. 12.24.1 BGI Company Information
  141. 12.24.2 BGI Business Overview
  142. 12.24.3 BGI Revenue in Premarital Genetic Testing Business (2021-2026)
  143. 12.24.4 BGI Premarital Genetic Testing Product Portfolio
  144. 12.24.5 BGI Recent Developments
  145. 12.25 WuXi AppTec
  146. 12.25.1 WuXi AppTec Company Information
  147. 12.25.2 WuXi AppTec Business Overview
  148. 12.25.3 WuXi AppTec Revenue in Premarital Genetic Testing Business (2021-2026)
  149. 12.25.4 WuXi AppTec Premarital Genetic Testing Product Portfolio
  150. 12.25.5 WuXi AppTec Recent Developments
  151. 12.26 Novogene
  152. 12.26.1 Novogene Company Information
  153. 12.26.2 Novogene Business Overview
  154. 12.26.3 Novogene Revenue in Premarital Genetic Testing Business (2021-2026)
  155. 12.26.4 Novogene Premarital Genetic Testing Product Portfolio
  156. 12.26.5 Novogene Recent Developments
  157. 12.27 Berry Genomics
  158. 12.27.1 Berry Genomics Company Information
  159. 12.27.2 Berry Genomics Business Overview
  160. 12.27.3 Berry Genomics Revenue in Premarital Genetic Testing Business (2021-2026)
  161. 12.27.4 Berry Genomics Premarital Genetic Testing Product Portfolio
  162. 12.27.5 Berry Genomics Recent Developments
  163. 12.28 Kingmed Diagnostic
  164. 12.28.1 Kingmed Diagnostic Company Information
  165. 12.28.2 Kingmed Diagnostic Business Overview
  166. 12.28.3 Kingmed Diagnostic Revenue in Premarital Genetic Testing Business (2021-2026)
  167. 12.28.4 Kingmed Diagnostic Premarital Genetic Testing Product Portfolio
  168. 12.28.5 Kingmed Diagnostic Recent Developments
  169. 12.29 Zhongyuan Concord
  170. 12.29.1 Zhongyuan Concord Company Information
  171. 12.29.2 Zhongyuan Concord Business Overview
  172. 12.29.3 Zhongyuan Concord Revenue in Premarital Genetic Testing Business (2021-2026)
  173. 12.29.4 Zhongyuan Concord Premarital Genetic Testing Product Portfolio
  174. 12.29.5 Zhongyuan Concord Recent Developments
  175. 12.30 AmoyDx
  176. 12.30.1 AmoyDx Company Information
  177. 12.30.2 AmoyDx Business Overview
  178. 12.30.3 AmoyDx Revenue in Premarital Genetic Testing Business (2021-2026)
  179. 12.30.4 AmoyDx Premarital Genetic Testing Product Portfolio
  180. 12.30.5 AmoyDx Recent Developments
13 Report Conclusion
    14 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research, Inc.
      Talk to an analyst